Search research articles
Contact Us
Filters
Showing results (21-30 of 95) with videos related to
Page
of 10
Sort By:
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy
|
May 25, 2015
New mechanisms for old drugs: Insights into DNA-unrelated effects of platinum compounds and drug resistance determinants
Laura Gatti, Giuliana Cassinelli, Nadia Zaffaroni, et al.
European Journal of Medicinal Chemistry
|
August 31, 2017
Overcoming ABC transporter-mediated multidrug resistance: The dual role of tyrosine kinase inhibitors as multitargeting agents
Giovanni Luca Beretta, Giuliana Cassinelli, Marzia Pennati, et al.
Biochemical Pharmacology
|
January 28, 2006
Sensitization to gimatecan-induced apoptosis by tumor necrosis factor-related apoptosis inducing ligand in prostate carcinoma cells
Paola Perego, Emilio Ciusani, Laura Gatti, et al.
Current Pharmaceutical Design
|
September 15, 2012
Modulation of sensitivity to antitumor agents by targeting the MAPK survival pathway
Giacomo Cossa, Laura Gatti, Giuliana Cassinelli, et al.
International Journal of Molecular Sciences
|
August 26, 2023
Lipidomic Approaches in Common and Rare Cerebrovascular Diseases: The Discovery of Unconventional Lipids as Novel Biomarkers
Antonella Potenza, Gemma Gorla, Tatiana Carrozzini, et al.
Current Medicinal Chemistry
|
April 7, 2016
Role of the Receptor Tyrosine Kinase Axl and its Targeting in Cancer Cells
Cristina Corno, Laura Gatti, Cinzia Lanzi, et al.
Pediatric Dermatology
|
April 29, 2026
Calcinosis Cutis and Delayed-Onset Myositis in a Case of Suspected Localized Scleroderma: A Diagnostic and Therapeutic Challenge
Edoardo Marrani, Laura Gatti, Ilaria Pagnini, et al.
Journal of Inorganic Biochemistry
|
February 19, 2008
Defining targets of modulation of human tumor cell response to cisplatin
Giovanni Luca Beretta, Laura Gatti, Elisabetta Corna, et al.
Anticancer Research
|
July 3, 2019
AXL Downstream Targeting Unravels Synergistic Drug Combinations in Ovarian Carcinoma Cells
Desirè M Alampi, Emilio Ciusani, Nives Carenini, et al.
Clinical and Experimental Rheumatology
|
April 9, 2025
IL-17A as potential novel biomarker and promising therapeutic target in Kawasaki disease patients
Maria Vincenza Mastrolia, Emanuela Ferraro, Edoardo Marrani, et al.
Page
of 10
Search research articles
Search
Showing results (21-30 of 95) with videos related to
Sort By:
Page
of 10
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy
|
May 25, 2015
New mechanisms for old drugs: Insights into DNA-unrelated effects of platinum compounds and drug resistance determinants
Laura Gatti, Giuliana Cassinelli, Nadia Zaffaroni, et al.
European Journal of Medicinal Chemistry
|
August 31, 2017
Overcoming ABC transporter-mediated multidrug resistance: The dual role of tyrosine kinase inhibitors as multitargeting agents
Giovanni Luca Beretta, Giuliana Cassinelli, Marzia Pennati, et al.
Biochemical Pharmacology
|
January 28, 2006
Sensitization to gimatecan-induced apoptosis by tumor necrosis factor-related apoptosis inducing ligand in prostate carcinoma cells
Paola Perego, Emilio Ciusani, Laura Gatti, et al.
Current Pharmaceutical Design
|
September 15, 2012
Modulation of sensitivity to antitumor agents by targeting the MAPK survival pathway
Giacomo Cossa, Laura Gatti, Giuliana Cassinelli, et al.
International Journal of Molecular Sciences
|
August 26, 2023
Lipidomic Approaches in Common and Rare Cerebrovascular Diseases: The Discovery of Unconventional Lipids as Novel Biomarkers
Antonella Potenza, Gemma Gorla, Tatiana Carrozzini, et al.
Current Medicinal Chemistry
|
April 7, 2016
Role of the Receptor Tyrosine Kinase Axl and its Targeting in Cancer Cells
Cristina Corno, Laura Gatti, Cinzia Lanzi, et al.
Pediatric Dermatology
|
April 29, 2026
Calcinosis Cutis and Delayed-Onset Myositis in a Case of Suspected Localized Scleroderma: A Diagnostic and Therapeutic Challenge
Edoardo Marrani, Laura Gatti, Ilaria Pagnini, et al.
Journal of Inorganic Biochemistry
|
February 19, 2008
Defining targets of modulation of human tumor cell response to cisplatin
Giovanni Luca Beretta, Laura Gatti, Elisabetta Corna, et al.
Anticancer Research
|
July 3, 2019
AXL Downstream Targeting Unravels Synergistic Drug Combinations in Ovarian Carcinoma Cells
Desirè M Alampi, Emilio Ciusani, Nives Carenini, et al.
Clinical and Experimental Rheumatology
|
April 9, 2025
IL-17A as potential novel biomarker and promising therapeutic target in Kawasaki disease patients
Maria Vincenza Mastrolia, Emanuela Ferraro, Edoardo Marrani, et al.
Page
of 10